STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Disponible desde:

Sanofi-Aventis Australia Pty Ltd

Designación común internacional (DCI):

prochlorperazine mesilate

formulario farmacéutico:

Injection

Composición:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Vía de administración:

Intramuscular

Unidades en paquete:

10 x 1 mL

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Resumen del producto:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2007-07-16